Editorial & Opinion
Hairy cell leukemia variant and WHO classification correspondence Re: 5 th edition WHO classification haematolymphoid tumors: lymphoid neoplasms.
| العنوان: | Hairy cell leukemia variant and WHO classification correspondence Re: 5 th edition WHO classification haematolymphoid tumors: lymphoid neoplasms. |
|---|---|
| المؤلفون: | Grever M; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA. michael.grever@osumc.edu., Andritsos L; Division of Hematology Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA., Anghelina M; Center for Biostatistics, The Ohio State University, Columbus, OH, USA., Arons E; Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, MD, USA., Banerji V; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, and Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, MB, Canada., Barrientos J; Mount Sinai Medical Center Miami, Miami, FL, USA., Bhat SA; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Blachly J; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Broccoli A; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico 'Sant'Orsola-Malpighi', and Department of Medical and Surgical Sciences - University of Bologna, Bologna, Italy., Call T; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dearden C; The Royal Marsden NHS Foundation Trust, London, UK., Dietrich S; University Hospital of Düsseldorf, Düsseldorf, Germany., Else M; The Institute of Cancer Research, London, UK., Epperla N; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Fagarasanu A; University of Alberta, Edmonton, AB, Canada., Falini B; Institute of Hematology and Center for Hemato-Oncological Research (CREO), University of Perugia and Santa Maria della Misericordia Hospital, Perugia, Italy., Forconi F; Cancer Sciences and Haematology Department, University of Southampton and Cancer Care, Haematology Department, Southampton NHS University Hospital Trust, Southampton, UK., Gozzetti A; Department of Medicine, Surgery and Neurosciences, University of Siena Policlinico S Maria alle Scotte, Siena, Italy., Hampel P; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hermel DJ; Division of Hematology and Oncology, Scripps Clinic, La Jolla, CA, USA., Iyengar S; The Royal Marsden NHS Foundation Trust, London, UK., Johnston JB; Department of Medicine, University of Manitoba, Winnipeg, MB, Canada., Juliusson G; Lund University/Dept of Hematology, Skåne University Hospital, Lund, Sweden., Kreitman RJ; Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, MD, USA., Lauria F; University of Siena, Siena, Italy., Lozanski G; Department of Pathology, The Ohio State University Medical Center, Columbus, OH, USA., Oakes CC; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Parikh SA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Park J; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Quest G; Pathology and Molecular Medicine, Queen's University and Kingston Health Sciences Centre, Kingston, ON, Canada., Rai K; Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA., Ravandi F; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Robak T; Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland., Rogers KA; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Saven A; Division of Hematology and Oncology, Scripps Clinic, La Jolla, CA, USA., Seymour JF; Peter MacCallum Cancer Centre, Royal Melbourne Hospital & University of Melbourne, Melbourne, VIC, Australia., Tadmor T; Hematology Unit, Bnai Zion Medical Center, and the Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Tallman MS; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA., Tam CS; Alfred Hospital and Monash University, Melbourne, VIC, Australia., Tiacci E; Institute of Hematology and Center for Hemato-Oncological Research (CREO), University of Perugia and Santa Maria della Misericordia Hospital, Perugia, Italy., Troussard X; Department of Hematology, Centre Hospitalier Universitaire Cote de Nacre, Caen, France., Wörmann B; The Charité - Universitätsmedizin, Berlin, Germany., Zent CS; James P. Wilmot Cancer Institute and Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Zenz T; Dept. of Medical Oncology & Haematology, Univerity Hospital and University of Zurich; The LOOP Zurich - Medical Research Center, Zurich, Switzerland., Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico 'Sant'Orsola-Malpighi', and Department of Medical and Surgical Sciences - University of Bologna, Bologna, Italy. |
| المصدر: | Leukemia [Leukemia] 2024 Jul; Vol. 38 (7), pp. 1642-1644. Date of Electronic Publication: 2024 Jun 08. |
| نوع المنشور: | Letter |
| اللغة: | English |
| بيانات الدورية: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2000- : London : Nature Publishing Group, Specialist Journals Original Publication: [Baltimore, Md.] : Williams & Wilkins, [c1987- |
| مواضيع طبية MeSH: | Leukemia, Hairy Cell*/pathology , Leukemia, Hairy Cell*/classification , Leukemia, Hairy Cell*/diagnosis , World Health Organization*, Humans |
| References: | Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720–48. (PMID: 10.1038/s41375-022-01620-2357328299214472) Coupland SE, Du MQ, Ferry JA, deJong D, Khoury JD, Leoncini L, et al. The fifth edition WHO classification of mature B-Cell neoplasms: open questions for research. J Pathol. 2024;262:255–70. (PMID: 10.1002/path.624638180354) Grever MR, Abdel-Wahab O, Andritsos LA, Banerji V, Barrientos J, Blachly JS, et al. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood. 2017;129:553–60. (PMID: 10.1182/blood-2016-01-689422279035285290982) Matutes E. Diagnostic and therapeutic challenges in hairy cell leukemia-variant: where are we in 2021? Expert Rev Hematol. 2021;14:355–63. (PMID: 10.1080/17474086.2021.190812133759673) Chihara D, Arons E, Stetler-Stevenson M, Yuan C, Wang HW, Zhou H, et al. Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant. Blood Adv. 2021;5:4807–16. (PMID: 10.1182/bloodadvances.2021005039346073489153043) Tiacci E, De Carolis L, Simonetti E, Capponi M, Ambrosetti A, Lucia E, et al. Vemurafenib plus rituximab in refractory or relapsed hairy-cell leukemia. N Engl J Med. 2021;384:1810–23. (PMID: 10.1056/NEJMoa203129833979489) Andritsos LA, Grieselhuber NR, Anghelina M, Rogers KA, Roychowdhury S, Reeser JW, et al. Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia. Leuk Lymphoma. 2018;59:1008–11. (PMID: 10.1080/10428194.2017.136585328918710) Rogers KA, Andritsos LA, Wei L, McLaughlin EM, Ruppert AS, Anghelina M, et al. Phase 2 study of ibrutinib in classic and variant hairy cell leukemia. Blood. 2021;137:3473–83. (PMID: 10.1182/blood.2020009688337546428225920) Forconi F, Ashton-Key M, Meakin N. BCL2 inhibition in refractory hairy-cell leukemia. N Engl J Med. 2023;388:2010–2. (PMID: 10.1056/NEJMc221561337224205) Tiacci E, De Carolis L, Santi A, Falini B. Venetoclax in relapsed or refractory hairy-cell leukemia. N Engl J Med. 2023;388:952–4. (PMID: 10.1056/NEJMc221613536884329) |
| تواريخ الأحداث: | Date Created: 20240608 Date Completed: 20240702 Latest Revision: 20240711 |
| رمز التحديث: | 20240712 |
| مُعرف محوري في PubMed: | PMC11216987 |
| DOI: | 10.1038/s41375-024-02280-0 |
| PMID: | 38851853 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1476-5551 |
|---|---|
| DOI: | 10.1038/s41375-024-02280-0 |